139 related articles for article (PubMed ID: 26669681)
1. Computational characterisation of the interactions between human ST6Gal I and transition-state analogue inhibitors: insights for inhibitor design.
Montgomery A; Szabo R; Skropeta D; Yu H
J Mol Recognit; 2016 May; 29(5):210-22. PubMed ID: 26669681
[TBL] [Abstract][Full Text] [Related]
2. Transition state-based ST6Gal I inhibitors: Mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensation.
Montgomery AP; Skropeta D; Yu H
Sci Rep; 2017 Oct; 7(1):14428. PubMed ID: 29089525
[TBL] [Abstract][Full Text] [Related]
3. Computer-aided design of human sialyltransferase inhibitors of hST8Sia III.
Dobie C; Montgomery AP; Szabo R; Skropeta D; Yu H
J Mol Recognit; 2018 Feb; 31(2):. PubMed ID: 29119617
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I.
Montgomery AP; Dobie C; Szabo R; Hallam L; Ranson M; Yu H; Skropeta D
Bioorg Med Chem; 2020 Jul; 28(14):115561. PubMed ID: 32616185
[TBL] [Abstract][Full Text] [Related]
5. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
[TBL] [Abstract][Full Text] [Related]
7. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
Li W; Niu Y; Xiong DC; Cao X; Ye XS
J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
[TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of sulfonate and sulfate analogues of lithocholic acid: A bioisosterism-guided approach towards the discovery of potential sialyltransferase inhibitors for antimetastatic study.
Perez SJLP; Chen CL; Chang TT; Li WS
Bioorg Med Chem Lett; 2024 Jun; 105():129760. PubMed ID: 38641151
[TBL] [Abstract][Full Text] [Related]
9. Conformational and electrostatic analysis of S
Crous W; Naidoo KJ
Bioorg Med Chem; 2016 Oct; 24(20):4998-5005. PubMed ID: 27614914
[TBL] [Abstract][Full Text] [Related]
10. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid.
Gross HJ; Merling A; Moldenhauer G; Schwartz-Albiez R
Blood; 1996 Jun; 87(12):5113-26. PubMed ID: 8652824
[TBL] [Abstract][Full Text] [Related]
11. The structure of human α-2,6-sialyltransferase reveals the binding mode of complex glycans.
Kuhn B; Benz J; Greif M; Engel AM; Sobek H; Rudolph MG
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1826-38. PubMed ID: 23999306
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.
Izumi M; Wada K; Yuasa H; Hashimoto H
J Org Chem; 2005 Oct; 70(22):8817-24. PubMed ID: 16238314
[TBL] [Abstract][Full Text] [Related]
13. Unliganded and CMP-Neu5Ac bound structures of human α-2,6-sialyltransferase ST6Gal I at high resolution.
Harrus D; Harduin-Lepers A; Glumoff T
J Struct Biol; 2020 Nov; 212(2):107628. PubMed ID: 32971290
[TBL] [Abstract][Full Text] [Related]
14. Recognition of cell surface acceptors by two human alpha-2,6-sialyltransferases produced in CHO cells.
Donadio S; Dubois C; Fichant G; Roybon L; Guillemot JC; Breton C; Ronin C
Biochimie; 2003; 85(3-4):311-21. PubMed ID: 12770770
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of α-Hydroxy-1,2,3-Triazole-linked Sialyltransferase Inhibitors and Evaluation of Selectivity Towards ST3GAL1, ST6GAL1 and ST8SIA2.
Szabo R; Dobie C; Montgomery A; Steele H; Yu H; Skropeta D
ChemMedChem; 2024 May; ():e202400088. PubMed ID: 38758134
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Bacterial α(2,6)-Sialyltransferase Reaction through an Inhibition of Its Inherent Sialidase Activity by Dephosphorylation of Cytidine-5'-Monophosphate.
Kang JY; Lim SJ; Kwon O; Lee SG; Kim HH; Oh DB
PLoS One; 2015; 10(7):e0133739. PubMed ID: 26231036
[TBL] [Abstract][Full Text] [Related]
17. Sialyltransferase inhibition and recent advances.
Wang L; Liu Y; Wu L; Sun XL
Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues.
Skropeta D; Schwörer R; Haag T; Schmidt RR
Glycoconj J; 2004; 21(5):205-19. PubMed ID: 15486453
[TBL] [Abstract][Full Text] [Related]
19. Characterization of sialyltransferase mutants using surface plasmon resonance.
Laroy W; Ameloot P; Contreras R
Glycobiology; 2001 Mar; 11(3):175-82. PubMed ID: 11320056
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a multifunctional α2,3-sialyltransferase from Pasteurella dagmatis.
Schmölzer K; Ribitsch D; Czabany T; Luley-Goedl C; Kokot D; Lyskowski A; Zitzenbacher S; Schwab H; Nidetzky B
Glycobiology; 2013 Nov; 23(11):1293-304. PubMed ID: 23969291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
